MAC enters a new week in an unusual position: short sellers who spent late April piling into the stock are now retreating, while analysts inch their price targets higher — and the two moves are happening at almost exactly the same time.
Short interest tells the more dramatic part of that story. After climbing from around 4.5% of the free float in early April to a six-week peak near 5% by mid-April, shorts started covering steadily. By May 12, SI had pulled back to roughly 4.1% of the free float — a 19% jump on the week in headline terms that looks alarming until you see it simply reflects a partial bounce off that April high. The month-on-month read is down 12%, and the direction of travel since mid-April has been clear cover, not accumulation. Days to cover runs near 7.9, which is elevated for a retail REIT but hardly extreme.
The borrow market offers no red flags for either side. Cost to borrow is a negligible 0.41%, and availability on the lending pool remains well-supplied — borrow is easy to initiate and easy to exit. The ORTEX short score has nudged up to 41.7 from the high-30s just two weeks ago, but it remains far from the danger zones that would flag meaningful squeeze or crowding risk. Options positioning is actually leaning bullish: the put/call ratio of 0.81 sits about one standard deviation below its 20-day average of 0.87, meaning call buying has picked up relative to put demand. The 52-week PCR range runs from 0.50 to 1.47, so 0.81 puts the current read in the cautiously constructive half of that band.
Analyst activity has been uniformly upward in direction for months, with the most recent move landing just this week. Citigroup's Nick Joseph — maintaining a Neutral rating — raised his target to $24 from $21 on May 13, a 14% lift that still implies meaningful upside to the $22.24 close. Evercore ISI moved its target to $22 from $21 a few days earlier. Both moves are incremental confirmations that the Street is slowly marking up estimates rather than calling a breakout. The mean consensus target now runs at $22.13 — almost exactly in line with the current price — suggesting the aggregate Street view has been caught up by the stock's own 17% YTD gain. Goldman Sachs and JP Morgan remain the key bears, with Sell and Underweight ratings respectively, though even Goldman raised its target from $15 to $17 back in March. EV/EBITDA runs at roughly 16.6x, down about 2.6 points over the past 30 days as the EBITDA base has been revised modestly higher.
Institutional ownership presents the most interesting subplot of the week. FMR (Fidelity) added 6.75 million shares in the period ending April 30, lifting its stake to 10.1% of shares outstanding. JP Morgan Asset Management added 3.6 million shares in the same window. Those are not passive index-tracking moves — they are active decisions by two of the largest fund managers in the world to meaningfully increase exposure to a mall REIT trading near its 52-week range. BlackRock, already the largest holder at 17.4%, also added a further 1.1 million shares. CenterSquare Investment Management, a specialist real estate manager, added 1.4 million shares. The breadth of the buying is notable against the backdrop of the short-seller retreat.
The fundamental backdrop is loss-making at the net income line — estimated EPS is -$0.14 for the period — but that is the usual REIT earnings-distortion from depreciation and interest expense on a $4.1 billion net debt load. EBITDA runs at roughly $674 million on revenues of $948 million, and operating cash flow was $304 million in the most recent reported period. The next earnings event is confirmed for June 1, and the most recent print in early May produced only a minor -0.6% next-day stock reaction, suggesting the quarterly releases have not been market-moving catalysts recently. The May 5 pre-announcement was more constructive, with a 3.4% 1-day and 3.4% 5-day move.
The June 1 event is therefore the natural next focal point: what to watch is whether the active institutional buying continues to put a floor under the stock even as shorts retain a modest position, and whether the Street's cautiously rising target consensus starts to pull further ahead of the current price.
See the live data behind this article on ORTEX.
Open MAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
